RxSight, Inc.
RXST
$12.62
-$0.47-3.59%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -35.73M | -32.25M | -26.55M | -27.46M | -30.69M |
| Total Depreciation and Amortization | 2.94M | 3.23M | 3.27M | 3.62M | 4.19M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 0.00 |
| Total Other Non-Cash Items | 23.18M | 21.13M | 17.58M | 16.10M | 14.37M |
| Change in Net Operating Assets | -9.05M | -8.93M | -10.77M | -9.21M | -8.85M |
| Cash from Operations | -18.66M | -16.82M | -16.47M | -16.95M | -20.99M |
| Capital Expenditure | -3.54M | -4.06M | -4.05M | -5.44M | -6.18M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 31.36M | 31.63M | -98.68M | -93.87M | -89.88M |
| Cash from Investing | 27.82M | 27.57M | -102.73M | -99.31M | -96.07M |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -47.00K | -39.00K | -47.00K | -61.00K | -83.00K |
| Issuance of Common Stock | 5.88M | 9.59M | 119.46M | 128.92M | 129.51M |
| Repurchase of Common Stock | -2.06M | -4.05M | -4.05M | -4.77M | -4.77M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -311.00K | -768.00K | -768.00K | -754.00K |
| Cash from Financing | 3.78M | 5.18M | 114.59M | 123.32M | 123.91M |
| Foreign Exchange rate Adjustments | 6.00K | 15.00K | 0.00 | -9.00K | 11.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -1.00K |
| Net Change in Cash | 12.95M | 15.95M | -4.61M | 7.05M | 6.86M |